Induction of human erythroleukemia (HEL) cells with nanomolar tumor-promoting phorbol myristate acetate (PMA) diesters results in the synchronous acquisition of multiple markers of the megakaryocyte phenotype. Induced cells markedly increase their content of cytoplasm and show features of morphological maturation. At the ultrastructural level, PMAtreated cells show increases in cytoplasm, nuclear lobulation and nucleolar content, and free ribosomes. Limited numbers of cells also express alpha-granules and nascent demarcation membrane systems. Functionally, PMA-stimulated HEL cells express increased amounts of the megakaryocyte/platelet proteins: glycoprotein IIb/IIIa, platelet factor 4, von Willebrand factor, glycoprotein Ib, and thrombospondin. No changes are observed in antigenic markers of the erythroid (glycophorin A) or macrophage lineages (MO-1 or MO-2). The increases in antigenic expression are rapid, reaching maximum levels within 3-4 d under serum-free conditions. Treatment with PMA also abruptly (within 1-2 d) inhibits cellular division in these cells. Washout studies indicate that phorbols exert their effect within 18-24 h, the approximate cell cycle time for these cells. Consistent with proliferative arrest, c-myc proto-oncogene transcripts begin to decline within 8 h of PMA treatment, although transcripts of c-myb are unaffected. Importantly, megakaryocyte differentiation is associated with endomitotic DNA synthesis (i.e., continued DNA synthesis in the absence of mitosis and cytokinesis), with HEL cells reaching a DNA content of 3-12 times that of unstimulated cells. 
Introduction
The study of lineage determination (commitment) during hematopoiesis is hindered by the unavailability of purified populations of multi-or pluripotent progenitor cells. Thus, examination of the intracellular events regulating hematopoietic de-erythroleukemia (HEL)' cells are a triphenotypic cell line constitutively expressing an erythroid phenotype, but also expressing antigens of the other lineages (1) (2) (3) . These cells increase their erythroid phenotype after stimulation with agents such as 6-aminolevulinic acid (4) . Similarly, an increase in macrophage phenotype occurs after high-dose (10-6 M) 4-flphorbol myristate acetate (PMA) treatment (5) . Inducible changes in megakaryocyte/platelet-associated antigens have also been reported (3, (6) (7) (8) (9) . However, little information exists on the capacity of HEL cells to undergo full megakaryocyte development.
Megakaryocyte development begins with the response of an early progenitor cell to microenvironmental influences. These initiate developmental programs which culminate in a mature platelet-shedding megakaryocyte. The entire process is promoted at several points by soluble regulatory cytokines, each with distinct and, in some cases, overlapping targets (8, 10, 1 1). Among these, the committed megakaryocyte progenitor cell and the immature megakaryocyte are the most sensitive to developmental signals, responding with predominantly proliferative or maturational development, respectively (8, 10, 12) . Ultimately, an understanding of the, intracellular events mediating megakaryocyte lineage determination and development requires biological, biochemical, and molecular analysis of purified populations of each of these megakaryocyte subpopulations. Unfortunately, the paucity of mature megakaryocytes and their precursors, coupled with technical difficulties in purifying cells of this lineage, precludes the use of native megakaryocytes in such studies. Thus, the availability of inducible cell lines capable of undergoing early megakaryocyte differentiation represents an important tool for the examination of the intracellular events occurring during megakaryocytopoiesis.
We hypothesized that HEL cells would be an excellent model in which to study megakaryocyte development, having the advantages of being inducible, displaying a pluripotent phenotype (allowing determination of the lineage specificity of induction), and a demonstrable, albeit low, constitutive expression of some megakaryocytic properties. We report that HEL cells respond to low-dose tumor promoting phorbol diesters by developing into megakaryoblast-like cells. This de-velopment is associated with the synchronous expression of multiple megakaryocyte phenotypic markers. In particular, PMA-treated HEL cells undergo the process of endomitosis, a unique developmental feature of megakaryocytes.
Methods
Cell cultivation and induction ofdifferentiation HEL were cultivated in RPMI-1640 medium containing a 10% fetal calf serum (FCS; Hyclone Laboratories, Logan, UT), 1 mM pyruvate, and 2 mM glutamate as described previously (3, 8) . For studies on the induction of differentiation, HEL cells were grown to a density of 1.5 X 106 cells/ml, washed twice in phosphate-buffered saline (PBS), and cultivated at 1 X 105 cells/ml in the presence or absence (control) of tumor-promoting phorbol diesters. Unless otherwise stated, all induction studies were carried out under serum-free conditions in RPMI (as above) containing 1% bovine serum albumin (BSA, wt/vol; Sigma Chemical Co., St. Louis, MO) . In certain instances, low-serum cultures were utilized which contained 0.5% FCS.
Tumor-promoting phorbol diesters were prepared as described previously (8, 13, 14) . HEL cells respond to tumor-promoting phorbol diesters, but not to the parent alcohol (phorbol) nor to phorbol diesters, such as phorbol 12, 13 diacetate, which lack tumor-promoting capacity, nor to the vehicle dimethyl sulfoxide (DMSO), which is 0.01% at 10-9 M PMA (8, 13, 14) .
Morphological, cytochemical, and ultrastructural studies
Morphological characterization was performed on May-Gruenwald/ Giemsa-stained cytocentrifuge preparations of HEL cells. Nitroblue tetrazolium (NBT)-reductase activity was examined utilizing a standard cytochemistry kit (Sigma Chemical Co., procedure No. 850); peripheral blood cells were used as a positive control. To preserve megakaryocyte morphology, HEL cells were collected in 5 vol of CATCH (citrate, adenosine, theophylline containing calcium-free Hanks' solution) media (15) , washed twice with CATCH, and cytocentrifuged (- 
Antibody specificity
The megakaryocyte antibodies used in these studies were described previously (3, 8) . These are antibodies to platelet factor 4 (17) labeled by random-priming (18) to a specific activity of 8 X 108 dpm/,ug. To detect c-myb-specific transcripts, we utilized a previously described SI nuclease protection assay (19) . In brief, a 1.5-kb Hind III fragment from the human c-myb expression vector, pMbm 1 (19) , was end-labeled with [32P]ATP using polynucleotide kinase to a specific activity of -7 X 107 dpm/ug. Next, 2 X 105 dpm of the probe were hybridized with 10 jtg of the total RNA as previously described (19) .
After digestion with 90 U of Sl nuclease (Sigma Chemical Co., St. Louis, MO) the reaction products were resolved on a 1% agarose gel. The gel was dried and subjected to autoradiography using an intensifying screen.
Determination ofDNA content byflow cytometry DNA content was determined by flow cytometry utilizing 7-aminoactomycin D (7AAD) as described previously (20) . This Cytometry data. The relationship between megakaryocyte antigen expression, or cell size indicated by FALS, and DNA content was examined by converting the mean logarithmic signal to a linear equivalent, using a previously reported algorithm (22, 23) . The mean specific antigen mean fluorescence content was then plotted vs. the mean DNA content.
Results
Morphological and ultrastructural changes occurring during PMA-induced megakaryocyte differentiation. In control cultures, HEL cells are deeply basophilic with a high nucleus/cytoplasm ratio (Fig. 1, A and B) and a relatively uncomplicated nuclear structure. Also, rare (< 0.4%) large megakaryocytelike cells are observed ( Fig. 1 A, arrow) . These cells retain their deep basophilia and high nucleus/cytoplasm ratio, but are increased in size and nuclear content. Within 3-5 d after PMA stimulation, HEL cells show a marked increase in cell size, cytoplasmic content, and nuclear complexity (Fig. 1 B) . The nuclei of these cells become larger and lobulated; the cytoplasm undergoes maturational changes becoming less basophilic and contains large regions of eosinophilia (contrast Fig.  1 , C and D).
Ultrastructural examination of uninduced HEL cells indicated a fairly typical immature hematopoietic cell with a high nucleus/cytoplasm ratio and moderate mitochondrial and ribosomal content (Fig. 2 a) . Examination of PMA-stimulated HEL cells by electron microscopy indicated a marked increase in cytoplasm, and an apparent increase in mitochondrial and free ribosome numbers, as well as lobulation of the nucleus (Fig. 2 b) . Additionally, membranous vesicles, which appear similar to regions of the nascent demarcation membrane system (DMS, which is felt to eventually delimit developing platelets; Fig. 2 b), were seen in a few cells along with rare cells containing few a-granule-like organelles (not shown).
Regulation of megakaryocyte antigen expression in HEL cells. After the induction of differentiation, quantitative changes occurred in the expression of megakaryocyte/plateletrelated proteins. Under serum-free conditions, low-dose PMA stimulation resulted in a significant increase (approximately sixfold above constitutive level) in the total amount of megakaryocyte antigen per cell (Fig. 3 A) . Significant increases occurred with as little as 0.3 nM PMA and optimal antigenic expression was observed at 2 nM. No further increases in megakaryocyte antigens were seen at concentrations up to 50 nM (concentrations > 10.0 nM not shown). Additionally, no alterations were seen over this range of PMA concentrations in the levels of macrophage antigens. The MO-I antigen shows a constitutive binding of 248 ± 98 pg/105 total nucleated cells; (mean+95% CI; n = 6) and no significant increases were observed between 0.1 and 10.0 nM PMA (e.g., expression at 10.0 nM is 317 ± 142 (n = 8). The MO-2 antigen is not detected on HEL cells nor did increases in expression occur over this range of PMA stimulation (not shown). Similarly, glycophorin A showed low constitutive expression which did not alter with PMA treatment (not shown). As well, PMA-treated HEL cells (over a range of 0. 1-10 nM) lack other macrophage characteristics; i.e., 90% of the cells are nonadherent and they are NBTreductase negative (not shown).
Analysis of individual antigen expression indicated that each reaches an optimum between 1.0 and 2.0 nM PMA (Fig.  3 B) . No significant differential peak responsiveness was noted for any individual platelet protein. At optimal (1.0-2.0 nM) PMA concentrations, Ilb/IIla showed the greatest increase being 13-fold greater than constitutive levels, PF4 was 3.8-fold increased, and TSP and vWF were 2.5-fold increased (for normative values see Fig. 3 B, legend). TSP showed an increased sensitivity in the lower ranges of PMA concentrations (0.1-0.3 nM). lb gave the weakest signal of all among the megakaryo- cyte antigens tested, being undetectable in untreated cultures, but significantly (sixfold) elevated at 1.0 nM PMA.
Studies on the rate of antigenic expression (at 2 nM PMA) in serum-free cultures demonstrated that the total content of megakaryocyte-related antigens significantly increased between days 2 and 3 of culture and reaches maximal levels of expression by day 4 (Fig. 4 A) . Individually, Ilb/Illa, PF4, Ib, and vWF all increased within 2-3 d of culture and reached maximal levels by day 4 (Fig. 4 B) . TSP was the sole exception to this developmental process, reaching maximal expression within 48 h of exposure to PMA.
Unfortunately, prolonged incubation (2 5 d) in serum-free cultures resulted in a loss in viability which was particularly evident in control (i.e., unstimulated) cultures. This low viability precluded the use of SPRIA studies due to nonspecific antibody binding. To examine later time periods, cultures were established which contained limiting amounts of serum (0.5% FCS). The addition of this small amount of serum improved viability in the controls, thus allowing analysis ofmaturation events occurring between days 4 and 10 of culture. Under these conditions, slight differences were noted in the kinetics of megakaryocyte antigen expression (not shown). Maximal antigenic expression in low-serum cultures was delayed by -3 d with maximal expression occurring on day 7.
Presumably, this delay is due to the increased proliferative drive functioning in opposition to the differentiation effects of PMA (vide infra).
Cessation ofproliferation as an index ofterminal differentiation in PMA-treated HEL cells. Logarithmically growing HEL cells (i.e., cells grown in 10% FCS during passage of the clone) increased 50-60-fold during 4 d of culture (not shown). These cells also proliferate in low-serum or serum-free cultures, although at greatly reduced rates (day 4 proliferation index 6 .1±2.0 (n = 10) vs 31.7±3.4 (n = 12); mean±95% CI; for serum-free and low-serum cultures, respectively). After the induction of differentiation, HEL cells decreased both their rate and degree of proliferation (Fig. 5 ). This inhibition of proliferation was sharply dependent on PMA concentration. At PMA concentrations of < 1 nM, no significant changes in proliferation index were observed compared to control, serum-free cultures (Fig. 5 A) . However, proliferation was significantly decreased at 2 nM PMA. HEL cells treated with 2 nM PMA have a proliferation index of 2.0 (in either serumfree or low-serum cultures, latter not shown) indicating that the treated cell population progressed through only a single round of proliferation after the induction of differentiation. The cessation of proliferation occurred between 2 and 3 d of culture after which no further proliferation is seen (Fig. 5 B) . Similar results occurred in low-serum cultures, with maximal inhibition occurring at 2 nM PMA, but the time period required to reach this reduction was delayed until days 5-7 (not shown).
To more precisely determine the effect of phorbol diesters on proliferation, we took advantage of the hydrophilic nature of PDBu, a tumor-promoting phorbol diester which is more readily washed out of cell membranes (24). Initial studies on the structure:activity relationship ofPDBu indicated that HEL cells responded similarly to PMA or PDBu, but that the latter required 10 nM concentrations to be biologically effective, presumably due to the lessened ability of this probe to intercalate into the cell membrane (24). Thus, PDBu washout experiments were performed to determine the precise time of exposure required to inhibit proliferation.
Exposure of HEL cells to 10 nM PDBu for 4-8 h resulted in a 50±8% reduction in proliferation (mean±95% CI; n = 3) vs. unstimulated controls, whereas 16 h of exposure to PDBu resulted in a 89±4% reduction in proliferation. To determine the exact period of pretreatment required to reach maximal inhibition of proliferation, PDBu washout data was normalized to percentage of peak effect: i.e., each preincubation data point was expressed as the percentage of maximal PDBu inhibition. These data (Fig. 5 C) show that maximal inhibition of proliferation occurred within 16 h of exposure to PDBu (the approximate cell cycle time for these cells), after which the inhibition of proliferation is complete.
Regulation ofproto-oncogene expression in HEL cells. We next examined the expression of the c-myc and c-myb protooncogenes in HEL cells after PMA exposure. We chose to study these two genes in particular, as their expression has been shown to be important for both normal hematopoietic and leukemic cell proliferation (25) (26) (27) . Furthermore, deregulated expression of either c-myc or c-myb has been shown to block the differentiation of some hematopoietic cell lines (28-31) although presumably through different mechanisms (32) . RNAs were prepared from HEL cells treated for different periods of time with 2 X 10-9 M PMA. To study c-myc expression, a Northern blot containing equivalent amounts of RNA was probed with a 32P-labeled c-myc cDNA. The resultant autoradiogram showed equivalent c-myc transcript levels up to 4 h after the addition of PMA. Thereafter, the levels of c-myc mRNA declined and were barely detectable 2-3 d later (Fig. 6 A) . This decline of c-myc expression correlated well with the timing of the loss of HEL proliferative capacity based on PDBU washout studies. Interestingly, despite the profound loss of c-myc expression, cellular DNA synthesis was maintained as HEL cells underwent endomitosis (vide infra).
In contrast to c-myc, no significant changes in c-myb transcript levels were observed, even after the longest periods of exposure to PMA (Fig. 6 B) . These observations thus indicate a fundamental difference in the control of c-myb mRNA expression in HEL cells as compared to other leukemic cell lines where terminal differentiation is commonly associated with down-regulation of c-myb (19, 33, 34) . Regulation ofHEL cell DNA content. Utilizing flow cytometry to examine PMA-treated cells, we observed that HEL cells markedly increased their DNA content during phorbol-induced differentiation. To determine whether proliferative status influences polyploidization, we examined cells induced with 1.0 nM PMA (at which no detectable reduction in proliferation occurs) and 2 nM (at which the cells cease to proliferate). After 7 d of culture, control cells demonstrated a DNA distribution equivalent to that of a predominantly quiescent cell population (Fig. 7) . The exception was a small number (a 10%) of HEL cells that constitutively committed to mega- (Fig. 6 A) 10 Mg of each RNA were electrophoreses in a 1% agarose-formaldehyde gel and transferred to a Nytran membrane. The blot was then hybridized with a murine c-myc cDNA insert (31) , and labeled with [32P]dCTP by the random priming method ( 18) to a sp act of -7 X 108 dpm/,ug. To detect c-myb transcripts (Fig. 6 B) an SI nuclease protection assay was used (19) . A 1.5-kb Hind III restriction fragment from the human c-myb expression plasmid pMbm 1 (19) cal of megakaryocytes, and not multiple nuclei (morphological data not shown). We directly explored the role of fusion in elevated DNA content by comparing the DNA content ofboth intact cells and cells stripped of cytoplasm (i.e., isolated nuclei). We hypothesized that if the polyploidy cells were multinuclear, then stripping the cytoplasm would result in a loss of the high ploidy classes with the redistribution ofthese nuclei to the 2C class, resulting in an increase in 2C frequency. This does not occur, as the two types of DNA analyses are equivalent (Fig. 7 B) . (20) . The DNA profiles are from a single representative experiment of six separate experiments. (C) Relationship of mean megakaryocyte antigen expression to mean relative DNA content. HEL cells were grown as above and stimulated with 2.0 nM PMA, and intact cells were analyzed for antigen expression and DNA content by flow cytometry as described in Methods. The data are expressed as the mean antigenic fluorescence for each ploidy class (ordinate, see Methods and [22, 23] gen expression are also those which acquire an increased DNA content, two-color flow cytometry was performed to correlate antigenic expression and DNA content in the same cell. As illustrated in Fig. 8 (GO/GI) DNA content with increases in DNA content equivalent to that of 1 nM PMA. Notably, these increases were only in the populations which also showed an increased antigen content.
We next examined the relationship between DNA content and cell size, using FALS as an index ofcell size. As do normal megakaryocytes, PMA-treated HEL cells show a positive correlation between DNA content and cell size (FALS). Similar to studies of antigenic expression, those cells with the highest DNA content also are the cells with the largest FALS or size (Fig. 9) . Thus, DNA content, cells size, and antigenic expression are all coordinately regulated in response to phorbol dies- Morphological examination of PMA-treated HEL cells reveals an increase in the degree of cytoplasmic maturation which is indicated by a marked reduction in basophilia and an increase in eosinophilia. Ultrastructural observations demonstrate increases in cytoplasm, nuclear complexity, and free ribosomes. Moreover, the nuclei of stimulated cells become lobulated and show increased numbers ofnucleoli. These morphological and ultrastructural observations are consistent with HEL cells reaching a maturation stage equivalent to that of either the promegakaryoblast or megakaryoblast. The promegakaryoblast (PMK-B), as defined by Breton-Gorius and co-workers (35) , is a small, morphologically unrecognizable megakaryocyte distinguished by its ultrastructure and the expression of platelet/megakaryocyte-associated antigenic markers (35, 36) . Ultrastructurally, these immature megakaryocytes contain large amounts ofrough endoplasmic reticulum, numerous mitochondria, ribosomes, and are devoid of agranules, with limiting amounts (if any) of DMS (35) . Megakaryoblasts are more mature than the PMK-B and represent the earliest megakaryocyte recognizable by light microscopy (35, 37) . Ultrastructurally, megakaryoblasts have increased amounts of DMS and contain easily identifiable a-granules (35) . Our (33, 50, 51) . As terminal differentiation is, by definition, accompanied by a cessation of DNA synthesis, some investigators have speculated that c-myc may be involved in this latter process (52, 53) . The unique ability of HEL cells to initiate endomitosis in the face of drastically lowered c-myc levels argues that the c-myc gene product is not required for DNA synthesis.
The actions of tumor-promoting phorbol diesters in inducing megakaryocyte differentiation suggest that the acquisition of a megakaryocyte phenotype as well as the endomitotic alteration in DNA synthesis, are mediated by protein kinase C, a calcium-dependent, serine-threonine protein kinase, which is the intracellular target for PMA (24, 54) . Our data show that the requirement for this differentiation signal is transient, irreversible (after 16-18 h) , and results in the cessation of proliferation followed by the synchronous acquisition ofa megakaryocyte phenotype. All of these observations are consistent with the activation of protein kinase C. Similarly, we previously demonstrated that both normal human megakaryocyte progenitor cells (8) as well as immature murine megakaryocytes (14) differentiate in the presence of phorbol diesters, which suggests that similar differentiation mechanisms exist in normal megakaryocytopoiesis. However, the association of differentiation with protein kinase C is limited by the known pleiotropic effects of PMA (55) (56) (57) (58) and the ability of protein kinase C to modulate other signal transduction systems (39) . In this regard, other data from our laboratory (using a murine system) document a role for adenylate cyclase in the proliferation of murine megakaryocyte progenitor cells (59, 60 megakaryocyte-associated antigens, lineage-specific morpho-logical and ultrastructural changes, and, importantly, the acquisition of an endomitotic DNA content. The pluripotent HEL cell line is thus an excellent model for examining the processes of lineage determination in hematopoietic cells because it shows inducible alterations in the macrophage, erythrocyte, and megakaryocyte phenotype. Importantly, these cells are a valuable model for understanding early events in megakaryocyte development such as regulation of platelet protein expression, or the intriguing process of endomitosis.
